Abstract

Advancements in the procurement, classification and storage of genetic material have yielded opportunities for increased sharing and collaboration across research networks. Such complex arrangements, however, pose unique problems for managers. As source material is drawn from disparate and often incompatible entities, standardised policies and practices are needed well before data is collected, transmitted and utilised by network collaborators. Presented here are some of the key intellectual property (IP) challenges facing managers of biomedical research, including examples of model agreements used in an innovative online tissue biomarker sharing network.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.